Non-inferiority of GlaxoSmithKline Biologicals' influenza vaccine (GSK576389A) 1 container over 2 container presentation in adults aged 65 years and over.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
At a glance
- Drugs GSK 576389A (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 16 Oct 2008 Primary outcome added as reported by ClinicalTrials.gov.
- 12 Oct 2008 Actual number of patients (1596) added as reported by CT.gov